Business Wire

Deutsche Bank and Ant International Announce Strategic Partnership to Provide Integrated Cross-Border Payment Solutions to Global Merchants

10.6.2025 11:30:00 CEST | Business Wire | Press Release

Share

Deutsche Bank and Ant International have announced their strategic partnership to provide more comprehensive payment solutions for businesses of all sizes in Europe and Asia, by combining their expertise and leveraging Ant International’s proprietary tokenisation and AI-based FX technology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250609586580/en/

From Left to Right: Sabih Behzad, Head of Digital Assets & Currencies Transformation for Deutsche Bank, Chintan Shah, Head of Corporate Coverage for APAC & MEA at Deutsche Bank, Kriti Jain, Head of New Economy Coverage APAC and Head of New Economy Cash Solutions Sales APAC & MEA at Deutsche Bank, Leiming Chen, Chief Sustainability Officer at Ant International, Yi Zhou, Chief Financial Officer at Ant International, Kelvin Li, General Manager of Platform Tech at Ant International and Yanyi Liang, Head of Whale Treasury Platform at Ant International

The bank will collaborate with Ant International’s Embedded Finance unit on a series of global treasury management and cross-border payment innovations, including tokenised deposits, stablecoin, and its Time-Series Transformer (TST) FX Model.

Deutsche Bank will be the first German bank to facilitate Ant International’s blockchain-based real-time treasury management platform to enable real-time fund transfers between Ant International’s intragroup entities. This will enable more efficient and transparent global treasury management for Ant.

In addition, the two sides will also explore cross-border payment innovations, including tokenised bank deposits, stablecoin and Ant International’s Falcon TST FX Model, to help Ant International and its clients reduce FX-related cost and risks. Both companies will also further look into the applications of stablecoins for global payments, including real-time cross-border treasury management for Ant’s entities, reserve management and on-ramp and off-ramp services.

Deutsche Bank will also work with Antom, a merchant payment and digitisation services provider, to scale up their collaboration to extend Antom’s acquiring solutions for merchants in EMEA, enabling them to be seamlessly integrated with more payment solutions.

The bank will also support WorldFirst’s suite of payments-related solutions for SMEs in e-commerce and cross-border trade, including but not limited to account collections, payments and FX services. It will also enable the account and financial service provider to access its global network to serve its clients.

Ole Matthiessen, Head of Corporate Bank APAC & MEA and Global Head of Cash Management for Deutsche Bank, said: “We are delighted to strategically cooperate with Ant International. We will leverage our broad product capabilities and strong global network to deliver seamless and secure payment solutions to Ant International and its customers in Europe and Asia. Given the dynamic landscape of financial services, we see great potential to collaborate with Ant International, as one of the world’s leading financial technology providers, to develop innovative payment solutions and transform the future of treasury management.”

Kelvin Li, General Manager of Platform Tech at Ant International, said: “With a dynamic fintech landscape, Europe is fast-becoming a key hub for global digital payment innovation. We are pleased to deepen our commitment to the region through this collaboration with Deutsche Bank, supporting the development of more seamless, secure and inclusive cross border payment solutions. By combining our digital and payment capabilities with a global leading financial institution, we aim to deliver enhanced payment experiences that meet the evolving needs of global businesses and consumers.”

Expanding on a client relationship that has been in place since 2019, the two sides signed a Memorandum of Understanding (MoU) on June 8 in Munich, Germany to deepen the strategic collaboration.

About Deutsche Bank

Deutsche Bank provides retail and private banking, corporate and transaction banking, lending, asset and wealth management products and services as well as focused investment banking to private individuals, small and medium-sized companies, corporations, governments and institutional investors. Deutsche Bank is the leading bank in Germany with strong European roots and a global network.

About Ant International

With headquarters in Singapore and main operations across Asia, Europe, the Middle East and Latin America, Ant International is a leading global digital payment, digitisation and financial technology provider. Through collaboration across the private and public sectors, our unified techfin platform supports financial institutions and merchants of all sizes to achieve inclusive growth through a comprehensive range of cutting-edge digital payment and financial services solutions. To learn more, please visit https://www.ant-intl.com/

About Antom

Ant International's Antom is the leading payment and digitisation services provider for merchants around the world. It offers unified merchant payment solutions to serve businesses of all sizes. Antom supports merchants to integrate over 300 payment methods, enabling them to connect with consumers in more than 200 markets, with the flexibility to accept payments in more than 100 currencies. Beyond payments, it provides digital marketing solutions and merchant digitisation services to help merchant streamline operations and enhance customer engagement. To learn more, please visit https://www.antom.com/.

About WorldFirst

WorldFirst offers cross-border payments and treasury services through its global business account, empowering growth for SMEs in e-commerce, trade, and the broad platform economy. WorldFirst simplifies key financial operations, including international payments, collections, currency conversions, and treasury management, all in a one-stop account. Leveraging the technological strengths of its parent company Ant International, WorldFirst delivers industry-leading transaction security and reliability. WorldFirst has supported over one million customers, enabling payments in 100+ currencies across more than 200 countries and regions. Learn more about WorldFirst at https://www.worldfirst.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250609586580/en/

Contacts

Media Contacts
Deutsche Bank
Kate Fields
Kate.fields@db.com

Ant International
Joshua Way
joshua.way@ant-intl.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press Release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press Release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press Release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye